Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹824Cr
Rev Gr TTM
Revenue Growth TTM
7.76%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

INDOAMIN
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 9.7 | -5.7 | 4.9 | -8.1 | 8.0 | 8.8 | 6.4 | 33.5 | 12.7 | 8.6 | 2.9 | 7.2 |
| 204 | 222 | 233 | 173 | 236 | 237 | 245 | 234 | 261 | 256 | 245 | 252 |
Operating Profit Operating ProfitCr |
| 13.2 | 8.9 | 8.0 | 10.7 | 6.9 | 10.4 | 8.9 | 9.4 | 8.7 | 10.9 | 11.5 | 9.1 |
Other Income Other IncomeCr | 2 | 4 | 5 | 2 | 5 | 8 | 5 | 2 | 0 | 16 | 5 | 2 |
Interest Expense Interest ExpenseCr | 5 | 6 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 |
Depreciation DepreciationCr | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 |
| 23 | 17 | 16 | 13 | 13 | 26 | 19 | 17 | 15 | 36 | 26 | 16 |
| 6 | 4 | 5 | 3 | 3 | 6 | 6 | 5 | 3 | 7 | 7 | 4 |
|
Growth YoY PAT Growth YoY% | 644.8 | 44.0 | 143.5 | -5.7 | -46.8 | 58.9 | 15.6 | 15.2 | 29.9 | 49.4 | 31.3 | 5.0 |
| 7.3 | 5.0 | 4.7 | 5.1 | 3.6 | 7.3 | 5.1 | 4.4 | 4.2 | 10.0 | 6.5 | 4.3 |
| 2.4 | 1.7 | 1.8 | 1.3 | 1.3 | 2.7 | 1.9 | 1.6 | 1.7 | 3.9 | 2.5 | 1.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 6.1 | 7.9 | 12.6 | 24.9 | 48.6 | -9.3 | 12.9 | 45.4 | 20.2 | -0.2 | 14.3 | 4.5 |
| 212 | 222 | 249 | 314 | 473 | 437 | 479 | 734 | 858 | 863 | 978 | 1,014 |
Operating Profit Operating ProfitCr |
| 9.6 | 11.9 | 12.6 | 11.5 | 10.5 | 8.8 | 11.3 | 6.6 | 9.2 | 8.5 | 9.4 | 10.1 |
Other Income Other IncomeCr | 1 | 1 | 3 | 4 | 7 | 7 | 8 | 10 | 4 | 16 | 15 | 23 |
Interest Expense Interest ExpenseCr | 5 | 4 | 4 | 8 | 10 | 11 | 9 | 14 | 17 | 22 | 22 | 24 |
Depreciation DepreciationCr | 10 | 12 | 12 | 12 | 15 | 20 | 11 | 14 | 17 | 15 | 17 | 20 |
| 8 | 15 | 23 | 25 | 38 | 18 | 49 | 35 | 57 | 58 | 77 | 93 |
| 3 | 6 | 7 | 9 | 13 | 6 | 12 | 11 | 16 | 15 | 21 | 22 |
|
| -8.8 | 73.2 | 78.2 | -1.4 | 57.9 | -49.2 | 192.5 | -38.5 | 77.4 | 5.1 | 30.1 | 26.4 |
| 2.2 | 3.6 | 5.7 | 4.5 | 4.8 | 2.7 | 6.9 | 2.9 | 4.3 | 4.5 | 5.2 | 6.3 |
| 0.8 | 1.4 | 2.5 | 2.3 | 3.6 | 1.7 | 5.3 | 3.3 | 5.8 | 5.9 | 7.7 | 9.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 33 | 33 | 33 | 33 | 33 | 33 | 35 | 35 | 35 | 36 | 36 | 36 |
| 12 | 17 | 36 | 48 | 90 | 100 | 127 | 152 | 190 | 228 | 281 | 324 |
Current Liabilities Current LiabilitiesCr | 101 | 102 | 127 | 143 | 192 | 189 | 236 | 314 | 309 | 304 | 372 | 391 |
Non Current Liabilities Non Current LiabilitiesCr | 10 | 15 | 17 | 22 | 29 | 38 | 54 | 52 | 62 | 67 | 89 | 91 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 99 | 112 | 102 | 159 | 209 | 211 | 265 | 340 | 373 | 396 | 471 | 496 |
Non Current Assets Non Current AssetsCr | 56 | 55 | 111 | 87 | 137 | 150 | 189 | 214 | 225 | 239 | 308 | 348 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 23 | 19 | 15 | 8 | 27 | 39 | 56 | 15 | 20 | 70 | 35 |
Investing Cash Flow Investing Cash FlowCr | -14 | -10 | -23 | -21 | -43 | -36 | -50 | -39 | -30 | -27 | -82 |
Financing Cash Flow Financing Cash FlowCr | -9 | -9 | 7 | 16 | 17 | -3 | -1 | 32 | 4 | -41 | 42 |
|
Free Cash Flow Free Cash FlowCr | 6 | 9 | -2 | -14 | -16 | 2 | 6 | -24 | -10 | 44 | -48 |
| 447.5 | 210.8 | 90.1 | 48.5 | 108.8 | 302.4 | 149.9 | 67.1 | 49.8 | 162.6 | 63.4 |
CFO To EBITDA CFO To EBITDA% | 104.6 | 63.6 | 40.6 | 19.0 | 49.7 | 92.0 | 91.6 | 29.6 | 23.4 | 87.3 | 35.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 66 | 123 | 238 | 284 | 314 | 95 | 311 | 655 | 548 | 787 | 836 |
Price To Earnings Price To Earnings | 13.8 | 15.0 | 14.9 | 17.8 | 12.4 | 7.4 | 8.3 | 28.7 | 13.6 | 18.9 | 15.1 |
Price To Sales Price To Sales | 0.3 | 0.5 | 0.8 | 0.8 | 0.6 | 0.2 | 0.6 | 0.8 | 0.6 | 0.8 | 0.8 |
Price To Book Price To Book | 1.5 | 2.5 | 3.5 | 3.6 | 2.6 | 0.7 | 1.9 | 3.5 | 2.5 | 3.1 | 2.6 |
| 4.8 | 5.4 | 8.1 | 8.8 | 7.7 | 5.1 | 7.4 | 16.1 | 8.7 | 12.3 | 10.9 |
Profitability Ratios Profitability Ratios |
| 28.1 | 35.4 | 34.0 | 33.3 | 30.3 | 33.0 | 35.1 | 30.8 | 30.6 | 30.0 | 32.2 |
| 9.6 | 11.9 | 12.6 | 11.5 | 10.5 | 8.8 | 11.3 | 6.6 | 9.2 | 8.5 | 9.4 |
| 2.2 | 3.6 | 5.7 | 4.5 | 4.8 | 2.7 | 6.9 | 2.9 | 4.3 | 4.5 | 5.2 |
| 14.7 | 19.5 | 21.3 | 20.2 | 19.7 | 11.2 | 18.1 | 12.3 | 16.2 | 16.7 | 16.5 |
| 11.7 | 18.2 | 23.4 | 19.8 | 20.5 | 9.7 | 23.0 | 12.3 | 18.1 | 16.3 | 17.6 |
| 3.4 | 5.5 | 7.6 | 6.5 | 7.3 | 3.5 | 8.3 | 4.2 | 6.8 | 6.8 | 7.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Indo Amines Limited (**IAL**), established in **1994**, is a premier South Asian manufacturer and global supplier of **Fine, Specialty, and Performance Chemicals**. With a product portfolio exceeding **500 items** and a presence in over **70 countries**, IAL operates as a vertically integrated player. The company leverages indigenous manufacturing technology and **DSIR-approved** in-house R&D to reduce dependency on imports, aligning with the "**Atmanirbhar Bharat**" initiative.
---
### **Core Market Segments and Global Footprint**
IAL serves a diverse array of high-growth end-user industries through five primary chemical segments. Exports are a critical pillar of the business, accounting for approximately **51.66%** of total production.
* **Primary Segments:** Fine Chemicals, Specialty Chemicals, Performance Chemicals, Perfumery Chemicals, and Active Pharmaceutical Ingredients (**APIs**).
* **Key End-User Industries:** Pharmaceuticals, Agrochemicals, Fertilizers, Petrochemicals, Road Construction, Pesticides, Dyes & Intermediates, and Personal Care.
* **Geographic Reach:** Operations span India, USA, Europe, Malaysia, China, Australia, and Japan.
* **Global Subsidiaries:**
* **Indo Amines Americas LLC** (USA)
* **Indo Amines (Europe) Ltd** (Europe)
* **Indo Amines (Malaysia) SDN BHD** (Malaysia)
* **Indo Amines (Changzhou) Co. Ltd** (China)
* **Indo Speciality Chemicals Pvt Ltd** (India - Reclassified as an **Associate** in **March 2026**).
---
### **Manufacturing Infrastructure and Capacity Scale-up**
IAL maintains a robust production footprint with a total installed capacity of **110,000 MTPA**. The company has aggressively expanded its capacity between **2023 and 2025** to meet rising global demand.
| Facility Location | Key Features & Recent Developments |
| :--- | :--- |
| **Dhule, Maharashtra** | Launched **Morpholine and Derivatives** in **April 2025**; features **ZLD** units. |
| **Mahad, Maharashtra** | Key administrative unit; received **Environmental Clearance** for capacity enhancement. |
| **Baroda, Gujarat** | Focuses on **Fine & Specialty Chemicals**; includes **EO plant** automation. |
| **Badlapur, Maharashtra** | Features **Biomass-fixed thermic fluid heaters** to replace furnace oil. |
| **Dombivli, Maharashtra** | Registered Office; **W-35** plant underwent restoration following a **2024** fire. |
**Recent Product Commercialization (Monthly Capacities):**
* **ADMA-8/10** (N, N-dimethyl Octanamide/Decanamide): **350 MT** (Dhule)
* **Benzoguanamine**, **CAMPA**, and **THIEC**: **300 MT** each (Mahad/Badlapur/Dhule)
* **OCG & PGG** (O-Cresyl / Phenyl Glycityl Ether): **250 MT** (W-38 Unit)
* **EHG** (Ethyl Hexyl Glycerin): **200 MT** (Mahad)
* **Specialty Amines (Bis-DAPA, DBAPA, Bis-MAPA)**: **200 MT** each (Sigma Unit)
---
### **Strategic Consolidation and Corporate Restructuring**
The company is executing a multi-pronged strategy to streamline operations, enhance synergies, and incentivize its workforce.
* **Amalgamation with Pious Engineering:** Completed in **November 2024** (effective **Jan 1, 2023**). IAL issued **1,890,000** equity shares to integrate engineering and fabrication capabilities, reducing administrative costs and strengthening the balance sheet.
* **Promoter Reclassification:** In **2024-2025**, several members were reclassified from 'Promoter' to 'Public', increasing public shareholding from **33.24%** to **42.74%**.
* **Asset Monetization:** Disposed of the **Rabale Unit** (Navi Mumbai) in **December 2023** and transferred leasehold land rights in **Q1 FY 2025-26** for **₹6 crore**, netting a gain of **₹5.95 crore**.
* **Indo ESOP Plan 2025:** Introduced to grant up to **725,000** stock options to employees, with a vesting period of **1 to 5 years**.
* **Global Partnerships:** Signed a Sales and Technology Agreement with **Indo Europe Additive SL (Spain)** in **September 2024** to expand the performance chemicals portfolio.
---
### **Financial Performance and Credit Profile**
IAL has demonstrated a consistent upward trajectory in revenue and profitability, supported by disciplined debt management.
**Consolidated Financial Summary:**
| Metric | FY 2021-22 | FY 2022-23 | FY 2023-24 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **₹786.04 Cr** | **₹945.01 Cr** | **₹959.78 Cr** |
| **Profit Before Tax** | **₹34.51 Cr** | **₹56.79 Cr** | **₹58.05 Cr** |
| **Profit After Tax** | **₹23.03 Cr** | **₹40.89 Cr** | **₹42.81 Cr** |
**Credit and Capital Strength:**
* **Credit Rating Upgrade:** In **April 2025**, **CRISIL** upgraded IAL to **CRISIL A-/Stable** (Long Term) and **CRISIL A2+** (Short Term).
* **Borrowing Capacity:** Shareholders approved doubling the borrowing limit from **₹500 Crores** to **₹1,000 Crores** in **January 2025** to fund expansion.
* **Dividend:** Recommended a **10%** final dividend (**₹0.50 per share**) for **FY 2023-24**.
---
### **R&D, Innovation, and Sustainability**
IAL is transitioning toward a high-value, low-carbon business model.
* **R&D Investment:** Investing **₹75 Crores** in continuous chemical synthesis and **decarboxylative ketonization** to scale up **Ketonic products**.
* **Climate Goals:** Committed to becoming **climate neutral by 2050**.
* **Green Initiatives:**
* **95%** of steam requirements are met using **Agro-mass briquettes**.
* Implementation of **Zero Liquid Discharge (ZLD)** across all units.
* Transition from furnace oil to **LPG** and **Biomass-fixed thermic fluid heaters**.
* **Certifications:** Holds **ISO 9001:2015**, **ISO 14001**, **ISO 45001**, and **ISO 22000**. Awarded **'Three Star Export House'** status in **July 2024**.
---
### **Risk Management and Business Continuity**
IAL employs a structured framework to mitigate operational, regulatory, and financial risks.
* **Operational Resilience:** Following a fire at the **W-35 Dombivli** unit in **June 2024** (inventory loss of **₹2.6 crore**), production was successfully shifted to alternate sites. The loss is being recovered via a **corporate insurance program**.
* **Regulatory Compliance:** Actively managing environmental norms. While the **Vadodara** unit faced a temporary closure notice in **2023**, the company has since reinforced its monsoon action plans and compliance protocols.
* **Market & Forex Risk:** IAL uses a **natural hedge** through its high export volume and utilizes **forward contracts** for USD exposure above predefined thresholds. It avoids speculative derivative trading.
* **Supply Chain:** To counter geopolitical volatility and competition from **Chinese producers**, IAL focuses on **process development** and **cost competitiveness** through its in-house R&D.